E-poster No. / 壁報編號
C06
Title / 題目
Efficacy and safety results by menopausal status in monarchE: adjuvant abemaciclib combined with endocrine therapy in patients with HR+, HER2- high-risk early breast cancer
First Author / 第一作者
Chiun-Sheng Huang
Institution / 單位
National Taiwan University Hospital and National Taiwan University College of Medicine, Taipei, Taiwan
Audio / 音訊檔
Author Group / 作者群
Chiun-Sheng Huang (Presenter)1, Shani Paluch-Shimon2, Patrick Neven3, Jens Huober4, Irfan Cicin5, Zefei Jiang6, Matthew P. Goetz7, Chikako Shimizu8, Ran Wei9, Sarah C. Nabinger9, Tammy Forrester9, Nadia Harbeck10
Author Group Institution/ 作者群單位
1National Taiwan University Hospital and National Taiwan University College of Medicine, Taipei, Taiwan; 2Hadassah University Hospital, Jerusalem, Israel; 3Universitaire Ziekenhuizen Leuven - Campus Gasthuisberg, Leuven, Belgium; 4University of Ulm, Breast Center, Ulm, Germany; 5Trakya University Faculty of Medicine, Edirne, Turkey; 6The Fifth Medical Center of PLA General Hospital, Beijing, China; 7Department of Oncology, Mayo Clinic, Rochester, MN, USA; 8National Center for Global Health and Medicine, Tokyo, Japan; 9Eli Lilly and Company, Indianapolis, IN, USA; 10Breast Center, LMU University Hospital, Munich, Germany
Category / 主題分類
Clinical Research
Keyword / 關鍵字
monarchE, Menopausal, Early breast cancer
